logo
Select company
Select metric
$ 6.69MNet Cash Flow - Investing
VS
Market
84
Sector
76
Industry
69
History
72
$ 9.84Close
$ 8.24 - $ 28.14 52-Week Range
Ticker Information

Ticker

NRIX

Company Name

NURIX THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NURIX THERAPEUTICS INC - Net Cash Flow - Investing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NRIX - CF - Investing Historical data
DateNet Cash Flow - Investing
9/30/2025$ 6.69M
6/30/2025$ -65.12M
3/31/2025$ -267.69M
12/31/2024$ -257.71M
9/30/2024$ -131.27M
6/30/2024$ -87.16M
3/31/2024$ 87.75M
12/31/2023$ 68.3M
9/30/2023$ 137.68M
6/30/2023$ 51.83M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NURIX THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Investing stands at $ -254.4M.
  • Over the past 5 years, NURIX THERAPEUTICS INC's average CF - Investing has been $ -74.79M.
  • The median CF - Investing for NURIX THERAPEUTICS INC during this period was $ -65.12M
  • NURIX THERAPEUTICS INC reached its highest CF - Investing over the past 5 years at $ 137.68M.
  • The lowest CF - Investing recorded by NURIX THERAPEUTICS INC in the same timeframe $ -292.14M

NURIX THERAPEUTICS INC's CF - Investing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Investing Benchmarks
CompanyCF - Investing
SNDX : SYNDAX PHARMACEUTICALS INC $ -46.1MURGN : UROGEN PHARMA LTD $ -43.69MTBPH : THERAVANCE BIOPHARMA INC $ -7.34MKURA : KURA ONCOLOGY INC $ -91.89MGYRE : GYRE THERAPEUTICS INC $ -5.47MZVRA : ZEVRA THERAPEUTICS INC $ -14.35MCRMD : CORMEDIX INC $ -14.39MNAGE : NIAGEN BIOSCIENCE INC $ -257KSAGE : SAGE THERAPEUTICS INC $ 254.43MEYPT : EYEPOINT PHARMACEUTICALS INC $ 8.1M

Definition of Net Cash Flow - Investing

[Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].

NRIX - Net Cash Flow - Investing, Last 5 years

$ -292.14M

Minimum

Jun 30, 2021

$ 137.68M

Maximum

Sep 30, 2023

$ -74.79M

Average

$ -65.12M

Median

CF - Investing Benchmark Analysis

The chart above depicts the distribution of CF - Investing for companies in the Total Stock Market. The average CF - Investing of the companies is $ -35.29M with a standard deviation of $ 83.34M.
The following table provides additional summary stats:
CF - Investing in the Market:
filtered constituents3.17K
min$ -292.23M
max$ 241M
average$ -35.29M
median$ -6.38M
std$ 83.34M